quinazolines has been researched along with Hepatoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, ZL; Huang, J; Zhen, LL | 1 |
| Liao, H; Liu, Y; You, Z; Zahng, J | 1 |
2 other study(ies) available for quinazolines and Hepatoblastoma
| Article | Year |
|---|---|
Knockdown of otubain 2 inhibits liver cancer cell growth by suppressing NF-κB signaling.
Topics: Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hepatoblastoma; Humans; Liver Neoplasms; Luciferases; Phenyl Ethers; Phenylenediamines; Phosphorylation; Quinazolines; RNA, Small Interfering; Signal Transduction; Survival Analysis; Thiolester Hydrolases; Transcription Factor RelA | 2020 |
[Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Quinazolines | 2014 |